CN112481341A - Preparation method and application of selenium absorption enhancing active peptide - Google Patents
Preparation method and application of selenium absorption enhancing active peptide Download PDFInfo
- Publication number
- CN112481341A CN112481341A CN202011414163.6A CN202011414163A CN112481341A CN 112481341 A CN112481341 A CN 112481341A CN 202011414163 A CN202011414163 A CN 202011414163A CN 112481341 A CN112481341 A CN 112481341A
- Authority
- CN
- China
- Prior art keywords
- selenium
- powder
- active peptide
- absorption
- added
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000011669 selenium Substances 0.000 title claims abstract description 179
- 229910052711 selenium Inorganic materials 0.000 title claims abstract description 179
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 title claims abstract description 177
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 90
- 238000010521 absorption reaction Methods 0.000 title claims abstract description 60
- 230000002708 enhancing effect Effects 0.000 title claims abstract description 29
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- 239000000843 powder Substances 0.000 claims abstract description 77
- 238000000855 fermentation Methods 0.000 claims abstract description 48
- 241000251468 Actinopterygii Species 0.000 claims abstract description 47
- 230000004151 fermentation Effects 0.000 claims abstract description 38
- 238000002156 mixing Methods 0.000 claims abstract description 28
- 239000006228 supernatant Substances 0.000 claims abstract description 24
- 102000007544 Whey Proteins Human genes 0.000 claims abstract description 21
- 108010046377 Whey Proteins Proteins 0.000 claims abstract description 21
- 235000021119 whey protein Nutrition 0.000 claims abstract description 21
- 210000003097 mucus Anatomy 0.000 claims abstract description 17
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims abstract description 14
- 240000000249 Morus alba Species 0.000 claims abstract description 12
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 12
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 12
- 239000007788 liquid Substances 0.000 claims abstract description 12
- 230000003068 static effect Effects 0.000 claims abstract description 12
- 244000000626 Daucus carota Species 0.000 claims abstract description 11
- 235000002767 Daucus carota Nutrition 0.000 claims abstract description 11
- 240000003183 Manihot esculenta Species 0.000 claims abstract description 11
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 claims abstract description 11
- 229920002472 Starch Polymers 0.000 claims abstract description 11
- 239000008107 starch Substances 0.000 claims abstract description 11
- 235000019698 starch Nutrition 0.000 claims abstract description 11
- 235000019483 Peanut oil Nutrition 0.000 claims abstract description 8
- 150000004676 glycans Chemical class 0.000 claims abstract description 8
- 239000000312 peanut oil Substances 0.000 claims abstract description 8
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 8
- 239000005017 polysaccharide Substances 0.000 claims abstract description 8
- 235000013402 health food Nutrition 0.000 claims abstract description 6
- 238000009210 therapy by ultrasound Methods 0.000 claims abstract description 5
- 238000000034 method Methods 0.000 claims description 23
- 238000003756 stirring Methods 0.000 claims description 20
- 241000233866 Fungi Species 0.000 claims description 10
- 102000010445 Lactoferrin Human genes 0.000 claims description 10
- 108010063045 Lactoferrin Proteins 0.000 claims description 10
- 229920002774 Maltodextrin Polymers 0.000 claims description 10
- 239000005913 Maltodextrin Substances 0.000 claims description 10
- 102000008114 Selenoproteins Human genes 0.000 claims description 10
- 108010074686 Selenoproteins Proteins 0.000 claims description 10
- 238000010438 heat treatment Methods 0.000 claims description 10
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 claims description 10
- 235000021242 lactoferrin Nutrition 0.000 claims description 10
- 229940078795 lactoferrin Drugs 0.000 claims description 10
- 229940035034 maltodextrin Drugs 0.000 claims description 10
- 230000001954 sterilising effect Effects 0.000 claims description 9
- 102000057297 Pepsin A Human genes 0.000 claims description 7
- 108090000284 Pepsin A Proteins 0.000 claims description 7
- 230000036541 health Effects 0.000 claims description 7
- 229940111202 pepsin Drugs 0.000 claims description 7
- 241001417978 Channidae Species 0.000 claims description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 5
- 240000007049 Juglans regia Species 0.000 claims description 5
- 235000009496 Juglans regia Nutrition 0.000 claims description 5
- 235000004347 Perilla Nutrition 0.000 claims description 5
- 244000124853 Perilla frutescens Species 0.000 claims description 5
- 235000013361 beverage Nutrition 0.000 claims description 5
- 239000000839 emulsion Substances 0.000 claims description 5
- 239000008103 glucose Substances 0.000 claims description 5
- 238000004806 packaging method and process Methods 0.000 claims description 5
- 239000007787 solid Substances 0.000 claims description 5
- 235000020234 walnut Nutrition 0.000 claims description 5
- 235000013305 food Nutrition 0.000 abstract description 11
- 150000001875 compounds Chemical class 0.000 abstract description 9
- 210000000813 small intestine Anatomy 0.000 abstract description 8
- 235000015097 nutrients Nutrition 0.000 abstract description 6
- 235000018102 proteins Nutrition 0.000 abstract description 5
- 102000004169 proteins and genes Human genes 0.000 abstract description 5
- 108090000623 proteins and genes Proteins 0.000 abstract description 5
- 210000001198 duodenum Anatomy 0.000 abstract description 4
- 210000002784 stomach Anatomy 0.000 abstract description 4
- 239000000796 flavoring agent Substances 0.000 abstract description 3
- 235000019634 flavors Nutrition 0.000 abstract description 3
- 235000012041 food component Nutrition 0.000 abstract description 3
- 239000005417 food ingredient Substances 0.000 abstract description 3
- 210000000936 intestine Anatomy 0.000 abstract description 3
- 238000012545 processing Methods 0.000 abstract description 3
- 235000013336 milk Nutrition 0.000 abstract description 2
- 239000008267 milk Substances 0.000 abstract description 2
- 210000004080 milk Anatomy 0.000 abstract description 2
- 229940091258 selenium supplement Drugs 0.000 description 155
- 235000011649 selenium Nutrition 0.000 description 151
- 239000000243 solution Substances 0.000 description 32
- 210000004027 cell Anatomy 0.000 description 19
- 230000029087 digestion Effects 0.000 description 18
- 230000000694 effects Effects 0.000 description 17
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical group [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 description 15
- 230000002496 gastric effect Effects 0.000 description 15
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 10
- 241000699670 Mus sp. Species 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 9
- 239000008280 blood Substances 0.000 description 9
- 230000000968 intestinal effect Effects 0.000 description 9
- 229960001471 sodium selenite Drugs 0.000 description 9
- 235000015921 sodium selenite Nutrition 0.000 description 9
- 239000011781 sodium selenite Substances 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 102000004196 processed proteins & peptides Human genes 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 6
- 238000007789 sealing Methods 0.000 description 6
- 230000004083 survival effect Effects 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 229940090949 docosahexaenoic acid Drugs 0.000 description 5
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 5
- 229940088598 enzyme Drugs 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 230000001502 supplementing effect Effects 0.000 description 5
- 206010028980 Neoplasm Diseases 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 4
- 239000008367 deionised water Substances 0.000 description 4
- 229910021641 deionized water Inorganic materials 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- 230000002779 inactivation Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000004659 sterilization and disinfection Methods 0.000 description 4
- 108091005658 Basic proteases Proteins 0.000 description 3
- 244000068988 Glycine max Species 0.000 description 3
- 235000010469 Glycine max Nutrition 0.000 description 3
- 239000012981 Hank's balanced salt solution Substances 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 239000003833 bile salt Substances 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 238000005520 cutting process Methods 0.000 description 3
- 230000001079 digestive effect Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 235000014106 fortified food Nutrition 0.000 description 3
- 238000000227 grinding Methods 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 235000004252 protein component Nutrition 0.000 description 3
- 238000004537 pulping Methods 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 238000003307 slaughter Methods 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 108010028690 Fish Proteins Proteins 0.000 description 2
- 102000004882 Lipase Human genes 0.000 description 2
- 108090001060 Lipase Proteins 0.000 description 2
- 239000004367 Lipase Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 239000006143 cell culture medium Substances 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 230000004700 cellular uptake Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000001676 hydride generation atomic fluorescence spectroscopy Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 235000019421 lipase Nutrition 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 125000003748 selenium group Chemical group *[Se]* 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 238000000527 sonication Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- OCKGFTQIICXDQW-ZEQRLZLVSA-N 5-[(1r)-1-hydroxy-2-[4-[(2r)-2-hydroxy-2-(4-methyl-1-oxo-3h-2-benzofuran-5-yl)ethyl]piperazin-1-yl]ethyl]-4-methyl-3h-2-benzofuran-1-one Chemical compound C1=C2C(=O)OCC2=C(C)C([C@@H](O)CN2CCN(CC2)C[C@H](O)C2=CC=C3C(=O)OCC3=C2C)=C1 OCKGFTQIICXDQW-ZEQRLZLVSA-N 0.000 description 1
- JDLKFOPOAOFWQN-VIFPVBQESA-N Allicin Natural products C=CCS[S@](=O)CC=C JDLKFOPOAOFWQN-VIFPVBQESA-N 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- JDLKFOPOAOFWQN-UHFFFAOYSA-N allicin Chemical compound C=CCSS(=O)CC=C JDLKFOPOAOFWQN-UHFFFAOYSA-N 0.000 description 1
- 235000010081 allicin Nutrition 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- 229940093761 bile salts Drugs 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000002784 cytotoxicity assay Methods 0.000 description 1
- 231100000263 cytotoxicity test Toxicity 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 231100000783 metal toxicity Toxicity 0.000 description 1
- VRDKYJSLDJDLML-UHFFFAOYSA-N methylselenol Chemical compound [Se]C VRDKYJSLDJDLML-UHFFFAOYSA-N 0.000 description 1
- 239000004530 micro-emulsion Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000002633 protecting effect Effects 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- -1 selenium ion Chemical class 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C21/00—Whey; Whey preparations
- A23C21/04—Whey; Whey preparations containing non-milk components as source of fats or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C21/00—Whey; Whey preparations
- A23C21/06—Mixtures of whey with milk products or milk components
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C21/00—Whey; Whey preparations
- A23C21/08—Whey; Whey preparations containing other organic additives, e.g. vegetable or animal products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L25/00—Food consisting mainly of nutmeat or seeds; Preparation or treatment thereof
- A23L25/30—Mashed or comminuted products, e.g. pulp, pastes, meal, powders; Products made therefrom, e.g. blocks, flakes, snacks; Liquid or semi-liquid products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The invention belongs to the technical field of food processing, and particularly relates to a preparation method and application of selenium absorption-enhancing active peptide, wherein the preparation method comprises the steps of carrying out anaerobic fermentation on supernatant liquid prepared from fish skin, whey protein powder, cassava starch, carrot powder and selenium-enriched yeast powder to obtain fermentation liquid, adding selenium protein to carry out ultrasonic treatment, mixing the fermentation liquid with solution consisting of fish skin mucus, mulberry leaf juice, peanut oil and algal polysaccharide, and finally carrying out high static pressure treatment to obtain the selenium absorption-enhancing active peptide; the selenium absorption-enhanced active peptide prepared by the invention is mainly a 6 peptide and 8 peptide compound and can be easily absorbed by the small intestine and the duodenum; meanwhile, the selenium-rich milk powder has a stable structure and good tolerance in the stomach and intestine, and can effectively enhance the absorption of the selenium by a human body; in addition, the selenium absorption enhancing active peptide can be matched with other nutrient components or food ingredients to prepare a selenium-rich health food form, so that the selenium absorption enhancing active peptide has good selenium absorption efficiency and unique flavor and is easily accepted by people.
Description
Technical Field
The invention belongs to the technical field of food processing, and particularly relates to a preparation method and application of selenium absorption-enhanced active peptide.
Background
Selenium is a trace element necessary for human body, which affects the health and development of human body, and the reference intake of dietary nutrients of Chinese residents recommends that 50 micrograms of selenium is needed every day. Selenium participates in the synthesis of various selenase and selenoprotein in a human body, the selenium can improve the immunity of the human body, promote the proliferation of lymphocytes and the synthesis of antibodies and immune globulin, the selenium has obvious inhibiting and protecting effects on colon cancer, skin cancer, liver cancer, breast cancer and other cancers, an intermediate metabolite methyl selenol in the body has strong anticancer activity, the selenium and vitamin E, allicin, linoleic acid, germanium, zinc and other nutrients have the synergistic antioxidant effect, the antioxidant activity is increased, and meanwhile, the selenium has the effects of reducing and relieving the heavy metal toxicity. Some researches prove that the selenium can effectively inhibit the growth of tumors, and a proper amount of selenium has good auxiliary improvement effect on patients after operation and radiotherapy and chemotherapy treatment. In addition, selenium is the most important anti-aging element discovered so far, and the research of experts of Chinese academy of sciences on the rural Bama with long life shows that: the selenium content in the barma soil and grains is about 10 times higher than the average level in China, and the selenium content in the blood of the centenarian is 3-6 times higher than that of normal people.
China is wide in territory, the content of selenium element in different soils is greatly different, and in some selenium-poor areas, the selenium content in crops is low, and the selenium content in food is not enough to supplement the needs of human bodies. Therefore, various selenium-rich foods are derived on the market, namely foods rich in trace element selenium; generally, the selenium-enriched food is divided into natural selenium-enriched food (also called plant active selenium food) and exogenous selenium-enriched food (also called artificial organic selenium food).
At present, various foods with selenium supplementing efficacy, such as selenium-enriched peanuts, selenium-enriched rice and the like, appear in the market, but most selenium supplementing foods are expensive, the selenium content of the selenium supplementing foods is uncertain, and the selenium in the selenium supplementing foods is influenced by the digestion and absorption of a human body, so that the selenium intake effect is not good. Therefore, the development of the selenium-rich health food for improving the selenium absorption efficiency has important value.
Disclosure of Invention
In order to overcome the defects of the prior art, the invention provides a preparation method of selenium absorption-enhanced active peptide, which utilizes biological fermentation and physical enhancement methods to improve the stability of combination of protein peptide and selenium, so that the flavor of selenium-enriched peptide can be enhanced, the selenium absorption effect of a human body can be improved, and the purpose of selenium supplement is achieved.
In order to achieve the purpose, the invention adopts the technical scheme that:
the invention provides a preparation method of active peptide for enhancing selenium absorption, which comprises the following steps:
s1, preparing fish skin into fish paste, adding pepsin for enzymolysis, and collecting supernatant;
s2, adding whey protein powder, cassava starch, carrot powder and selenium-enriched yeast powder into the supernatant obtained in the step S1, and then carrying out anaerobic fermentation;
s3, adding selenoprotein into the fermentation liquor obtained in the step S2, and then carrying out ultrasonic treatment;
s4, uniformly mixing the fish skin mucus and the mulberry leaf juice, standing for a period of time, adding peanut oil and algal polysaccharide, and then homogenizing and stirring;
s5, adding the solution obtained in the step S4 into the fermentation liquid obtained in the step S3, vacuumizing, performing high static pressure treatment, and finally reducing the pressure to obtain the selenium absorption enhancing active peptide.
Preferably, the fish skin and the fish skin mucus are both from snakeheads.
Selenium and protein are combined to form selenoprotein, so that the structural stability in a complex processing environment and a digestion environment can be enhanced, and the active selenium form is beneficial to the absorption of the selenium by a body and improves the bioavailability. The invention utilizes the yeast directional fermentation technology and the selenium peptide stable compound technology, utilizes the characteristic of strong absorptivity of the peptide to prepare the selenium-rich peptide with green safety and high bioavailability, the fish protein and the organic selenium form stable cross connection through high pressure, and then form a stable structure through the high static pressure variable pressure technology, so as to obtain 6 peptide and 8 peptide compounds which are easy to be absorbed by small intestine and duodenum, and enhance the absorption of intestinal mucosa cells to the organic selenium; meanwhile, the mixture of the body surface mucus of the snakeheads and the mulberry leaf juice can form micro-nano embedding after emulsification, so that the structure of the selenium peptide compound is not easily affected by gastrointestinal digestion, and the selenium peptide compound can smoothly reach the absorption part of the small intestine.
Preferably, in step S1, the amount of pepsin added is 20-40% of the weight of the fish paste, in order to obtain better enzymolysis effect.
Preferably, in order to enhance the effect of the directional fermentation, in step S2, whey protein powder, tapioca starch and carrot powder are added into the supernatant, the mixture is heated to 30 ℃, then selenium-enriched yeast powder is added, and finally the mixture is heated to 37 ℃ for anaerobic fermentation.
Preferably, in order to obtain a better fermentation effect, in step S2, according to the mass of the supernatant, the addition amount of the whey protein powder is 0.5-1.5%, the addition amount of the tapioca starch is 2.5-2.8%, the addition amount of the carrot powder is 0.3-0.5%, and the addition amount of the selenium-enriched yeast powder is 0.2-0.3%.
Preferably, in order to obtain a better emulsification effect, in step S4, the volume ratio of the fish skin mucus to mulberry leaf juice is 1: 1.
Preferably, in step S5, the high static pressure treatment is a high static pressure treatment at 300-350MPa for 10 minutes. Under the high static pressure treatment, the stable structure formed by the fish protein and the organic selenium is more favorably formed.
Preferably, the pH is one of the important conditions affecting the enzymolysis effect, and in step S1, the pH of the enzymolysis treatment is 3.8-4.2. Further, the pH of the enzymatic treatment is 4.0.
Preferably, to ensure the sufficient degree of enzymolysis, the enzymolysis treatment is stirring enzymolysis, i.e. stirring enzymolysis at a rotation speed of 200-.
Preferably, the temperature is raised to 80 ℃ for 10 minutes after the enzymolysis treatment, so as to achieve the effects of sterilization and enzyme inactivation.
Preferably, the fermentation is terminated when the anaerobic fermentation reaches a pH of 4.8.
Preferably, in step S3, the amount of selenoprotein added is 0.001% -0.003% of the total mass of the fermentation broth.
Preferably, to ensure adequate distribution of the selenoprotein into the fermentation broth, the power of the sonication is 300- "400W for 15-20 minutes in step S3.
Preferably, the acidity (pH4.8-5.0) and temperature (35 deg.C-40 deg.C) of the solution are controlled to be constant during the sonication in step S3.
Preferably, in step S4, the addition amount of the peanut oil is 10-15% of the total volume of the skin mucus and the mulberry leaf juice, and the addition amount of the algal polysaccharides is (0.5-0.8) wt% of the total mass of the skin mucus and the mulberry leaf juice.
Preferably, in order to ensure sufficient degree of stirring, the homogeneous stirring is performed at 42 ℃ to 46 ℃ for 30 to 40 minutes in step S4.
Preferably, to ensure that the selenopeptide compound is sufficiently emulsified to form micro-emulsion nano-particles, the volume ratio of the solution of step S4 to the fermentation broth of step S3 in step S5 is 1 (4-6). Further, the volume ratio of the solution of the step S4 to the fermentation liquid of the step S3 is 1: 5.
Preferably, in step S5, the pressure reduction is to (80-120) MPa and maintained for 10 minutes.
The invention also provides the selenium absorption enhancing active peptide prepared by the preparation method.
The invention also provides application of the selenium absorption enhancing active peptide in preparation of selenium-rich health food.
The selenium-enriched health food with various forms is prepared by matching the selenium-enriched absorption active peptide with other nutrient components or food ingredients, so that the healthy nutrient components of the active peptide can be improved, and selenium-enriched functional foods with various forms and good selenium absorption effects are formed.
The invention also provides a preparation method of the selenium-enriched emulsion beverage for enhancing selenium absorption, which comprises the following steps: adding 1.8-2 wt% of whey protein, 0.002-0.003 wt% of lactoferrin, 0.1-0.15 wt% of edible fungus superfine powder, 1.3-2.0 wt% of maltodextrin, 1.3-2.0 wt% of perilla extract and 1.3-2.0 wt% of glucose into the selenium-enriched active peptide, stirring, mixing uniformly, and sterilizing at high temperature to obtain the selenium-enriched active peptide.
The invention also provides a preparation method of the selenium-rich health powder for enhancing selenium absorption, which comprises the following steps: drying the selenium-enriched absorption active peptide into powder, adding 5-6 wt% of whey protein powder, 0.6-1.2 wt% of walnut powder, 0.001-0.0015 wt% of lactoferrin, 0.8-1.0 wt% of edible fungus superfine powder, 8-10 wt% of maltodextrin and 0.005-0.01 wt% of solid DHA (docosahexaenoic acid) powder, uniformly mixing and packaging to obtain the selenium-enriched absorption active peptide.
Compared with the prior art, the invention has the beneficial effects that:
the invention provides a preparation method of selenium absorption enhancing active peptide, which comprises the steps of carrying out anaerobic fermentation on supernatant liquid prepared from fish skin, whey protein powder, cassava starch, carrot powder and selenium-enriched yeast powder to obtain fermentation liquid, adding selenoprotein for ultrasonic treatment, mixing the fermentation liquid with solution consisting of fish skin mucus, mulberry leaf juice, peanut oil and algal polysaccharides, and finally carrying out high static pressure treatment to obtain the selenium absorption enhancing active peptide. The selenium absorption-enhanced active peptide prepared by the invention is mainly a 6 peptide and 8 peptide compound and can be easily absorbed by the small intestine and the duodenum; meanwhile, the selenium-enriched milk powder has a stable structure, is not easily influenced by gastrointestinal digestion, can smoothly reach the absorption part of the small intestine, has good tolerance in the stomach and intestine, and can effectively enhance the absorption of the selenium by the human body. In addition, the selenium absorption enhancing active peptide can be matched with other nutrient components or food ingredients to prepare a selenium-rich health food form, so that the selenium absorption enhancing active peptide has good selenium absorption efficiency and unique flavor and is easily accepted by people.
Detailed Description
The following further describes the embodiments of the present invention. It should be noted that the description of the embodiments is provided to help understanding of the present invention, but the present invention is not limited thereto. In addition, the technical features involved in the embodiments of the present invention described below may be combined with each other as long as they do not conflict with each other.
The experimental procedures in the following examples were carried out by conventional methods unless otherwise specified, and the test materials used in the following examples were commercially available by conventional methods unless otherwise specified.
Example 1A method for preparing an active peptide with enhanced selenium absorption
(1) Taking fresh snakeheads as raw materials, slaughtering, and respectively collecting fish skin and fish skin mucus;
(2) cutting the collected fish skin, pulping, adding pure water at 4 ℃ into the crushed fish skin according to the feed liquid weight ratio of 1:3, preparing the fish skin into fish paste by a wet superfine grinding technology, adjusting the pH value of the fish paste to 4.0, then adding pepsin according to 30% of the weight of the fish paste, mechanically stirring and performing enzymolysis for 2 hours at the rotating speed of 250 revolutions per minute, then centrifugally filtering 5000g to retain supernatant, and finally heating the supernatant to the temperature of 80 ℃, keeping the temperature for 10 minutes to achieve the effects of sterilization and enzyme inactivation.
(2) Pouring the supernatant into a fermentation tank, adding 1.0% of whey protein powder, 2.65% of cassava starch and 0.4% of carrot powder according to the mass of fish paste (supernatant), uniformly mixing, heating to 30 ℃, then adding 0.25% of selenium-rich yeast powder, uniformly mixing, continuously heating to 37 ℃, then sealing the fermentation tank for anaerobic fermentation for 3.5 hours, and stopping fermentation when the pH reaches 4.8.
(3) Adding 0.002% selenoprotein into the fermentation liquor according to the total mass of the fermentation liquor, uniformly mixing, and then acting in ultrasonic waves with the power of 350W for 17.5 minutes, wherein the acidity (pH4.9) and the temperature (37.5 ℃) of the fermentation liquor are controlled to be constant in the ultrasonic process.
(4) Uniformly mixing the fish skin mucus obtained by separation in the step (1) and the mulberry leaf juice according to the volume ratio of 1:1, standing for 10 minutes, adding peanut oil (volume percentage) with the total volume of 13 percent and algal polysaccharide with the total mass of 0.65wt percent, and homogenizing and stirring at 44 ℃ for 40 minutes for later use.
(5) Slowly adding the solution in the step (4) into the fermentation liquor in the step (3) according to the volume ratio of 1:5, uniformly stirring, then placing in a bag, vacuumizing, sealing, treating for 10 minutes at high static pressure of 330MPa, then reducing the pressure to 100MPa, and maintaining for 10 minutes to obtain the selenium-enriched active peptide solution for enhancing selenium absorption.
The main protein components in the selenium-rich active peptide solution are measured by referring to the method in GB/T22492-2008 soybean peptide powder, namely 6 peptides and 8 peptides.
Example 2A method for preparing active peptide with enhanced selenium absorption
(1) Taking fresh snakeheads as raw materials, slaughtering, and respectively collecting fish skin and fish skin mucus;
(2) cutting the collected fish skin, pulping, adding pure water at 4 ℃ into the crushed fish skin according to the feed liquid weight ratio of 1:3, preparing the fish skin into fish paste by a wet superfine grinding technology, adjusting the pH value of the fish paste to 4.0, then adding pepsin according to 20% of the weight of the fish paste, mechanically stirring and performing enzymolysis for 2 hours at the rotating speed of 200 r/min, then centrifugally filtering 5000g to retain supernatant, and finally heating the supernatant to the temperature of 80 ℃ for 10 minutes to achieve the effects of sterilization and enzyme inactivation.
(2) Pouring the supernatant into a fermentation tank, adding 0.5% of whey protein powder, 2.5% of cassava starch and 0.3% of carrot powder according to the mass of fish paste (supernatant), uniformly mixing, heating to 30 ℃, adding 0.2% of selenium-rich yeast powder, uniformly mixing, continuously heating to 37 ℃, then sealing the fermentation tank for anaerobic fermentation for 3.5 hours, and stopping fermentation when the pH value reaches 4.8.
(3) Adding 0.001% selenoprotein into the fermentation liquor according to the total mass of the fermentation liquor, uniformly mixing, and acting in ultrasonic waves with the power of 300W for 20 minutes, wherein the acidity (pH4.8) and the temperature (35 ℃) of the fermentation liquor are controlled to be constant in the ultrasonic process.
(4) Uniformly mixing the fish skin mucus obtained by separation in the step (1) and the mulberry leaf juice according to the volume ratio of 1:1, standing for 10 minutes, adding peanut oil (volume percentage) with the total volume of 10 percent and algal polysaccharide with the total mass of 0.5wt percent, and homogenizing and stirring at 42 ℃ for 40 minutes for later use.
(5) Slowly adding the solution in the step (4) into the fermentation liquor in the step (3) according to the volume ratio of 1:4, uniformly stirring, then placing in a bag, vacuumizing, sealing, treating for 10 minutes at a high static pressure of 300MPa, then reducing the pressure to 80MPa, and maintaining for 10 minutes to obtain the selenium-enriched active peptide solution for enhancing selenium absorption.
The main protein components in the selenium-rich active peptide solution are measured by referring to the method in GB/T22492-2008 soybean peptide powder, namely 6 peptides and 8 peptides.
Example 3A method for preparing active peptide with enhanced selenium absorption
(1) Taking fresh snakeheads as raw materials, slaughtering, and respectively collecting fish skin and fish skin mucus;
(2) cutting the collected fish skin, pulping, adding pure water at 4 ℃ into the crushed fish skin according to the feed liquid weight ratio of 1:3, preparing the fish skin into fish paste by a wet superfine grinding technology, adjusting the pH value of the fish paste to 4.0, then adding pepsin according to 40% of the weight of the fish paste, mechanically stirring and performing enzymolysis for 2 hours at the rotating speed of 300 r/min, then centrifugally filtering 5000g to retain supernatant, and finally heating the supernatant to the temperature of 80 ℃ for 10 minutes to achieve the effects of sterilization and enzyme inactivation.
(2) Pouring the supernatant into a fermentation tank, adding 1.5% of whey protein powder, 2.8% of cassava starch and 0.5% of carrot powder according to the mass of fish paste (supernatant), uniformly mixing, heating to 30 ℃, then adding 0.3% of selenium-rich yeast powder, uniformly mixing, continuously heating to 37 ℃, then sealing the fermentation tank for anaerobic fermentation for 3.5 hours, and stopping fermentation when the pH reaches 4.8.
(3) Adding 0.003% selenoprotein into the fermentation liquor according to the total mass of the fermentation liquor, uniformly mixing, and then acting in ultrasonic waves with the power of 400W for 15 minutes, wherein the acidity (pH5.0) and the temperature (40 ℃) of the fermentation liquor are controlled to be constant in the ultrasonic process.
(4) Uniformly mixing the fish skin mucus obtained by separation in the step (1) and the mulberry leaf juice according to the volume ratio of 1:1, standing for 10 minutes, adding peanut oil (volume percentage) with the total volume of 15 percent and algal polysaccharide with the total mass of 0.8wt percent, and homogenizing and stirring at 46 ℃ for 30 minutes for later use.
(5) Slowly adding the solution in the step (4) into the fermentation liquor in the step (3) according to the volume ratio of 1:6, uniformly stirring, then placing in a bag, vacuumizing, sealing, treating for 10 minutes at high static pressure of 350MPa, then reducing the pressure to 120MPa, and maintaining for 10 minutes to obtain the selenium-enriched active peptide solution for enhancing selenium absorption.
The main protein components in the selenium-rich active peptide solution are measured by referring to the method in GB/T22492-2008 soybean peptide powder, namely 6 peptides and 8 peptides.
Embodiment 4 a method for preparing selenium-enriched emulsion beverage for enhancing selenium absorption
Adding 1.9 wt% of whey protein, 0.0025 wt% of lactoferrin, 0.125 wt% of edible fungus superfine powder, 1.6 wt% of maltodextrin, 1.6 wt% of perilla extract and 1.6 wt% of glucose into the selenium-rich active peptide solution prepared in the example 1, stirring and uniformly mixing, and then sterilizing at high temperature to obtain the selenium-rich active peptide.
Example 5A method for preparing a selenium enriched emulsion beverage for enhanced selenium absorption
Adding 1.8 wt% of whey protein, 0.002 wt% of lactoferrin, 0.1 wt% of edible fungus superfine powder, 1.3 wt% of maltodextrin, 1.3 wt% of perilla extract and 1.3 wt% of glucose into the selenium-rich active peptide solution prepared in the example 1, stirring and uniformly mixing, and then sterilizing at high temperature to obtain the selenium-rich active peptide.
Embodiment 6A method for preparing a selenium-enriched emulsion beverage for enhancing selenium absorption
Adding 2 wt% of whey protein, 0.003 wt% of lactoferrin, 0.15 wt% of edible fungus superfine powder, 1.3 wt% of maltodextrin, 1.3 wt% of perilla extract and 1.3 wt% of glucose into the selenium-rich active peptide solution prepared in the example 1, stirring and uniformly mixing, and then sterilizing at high temperature to obtain the selenium-rich active peptide.
Embodiment 7 a method for preparing selenium-rich health powder for enhancing selenium absorption
The selenium-rich active peptide solution prepared in the embodiment 1 is spray-dried into light yellow selenium-rich active peptide powder, and then 5.5 wt% of whey protein powder, 0.9 wt% of walnut powder, 0.0013 wt% of lactoferrin, 0.9 wt% of edible fungus ultrafine powder, 9 wt% of maltodextrin and 0.008 wt% of solid DHA powder are added into the selenium-rich active peptide powder, and the selenium-rich active peptide solution is obtained after uniform mixing and packaging.
Embodiment 8 a method for preparing selenium-rich health powder for enhancing selenium absorption
The selenium-rich active peptide solution prepared in the embodiment 1 is spray-dried into light yellow selenium-rich active peptide powder, and then 5 wt% of whey protein powder, 0.6 wt% of walnut powder, 0.001 wt% of lactoferrin, 0.8 wt% of edible fungus superfine powder, 8 wt% of maltodextrin and 0.005 wt% of solid DHA powder are added into the selenium-rich active peptide powder, and the selenium-rich active peptide solution is obtained after uniform mixing and packaging.
Embodiment 9 a method for preparing selenium-rich health powder for enhancing selenium absorption
The selenium-rich active peptide solution prepared in the embodiment 1 is spray-dried into light yellow selenium-rich active peptide powder, and then 6 wt% of whey protein powder, 1.2 wt% of walnut powder, 0.0015 wt% of lactoferrin, 1.0 wt% of edible fungus superfine powder, 10 wt% of maltodextrin and 0.01 wt% of solid DHA powder are added into the selenium-rich active peptide powder, and the selenium-rich active peptide solution is obtained after uniform mixing and packaging.
Experimental example 1 in vitro digestion and absorption experiment of Small intestinal mucosal cancer cells (Caco-2)
(1) Cytotoxicity assay (survival):
caco-2 cells were cultured at 1X 104The density of individual cells/well was plated in collagen-coated 96-well plates, which were incubated at 37 ℃ with CO2Incubate in incubator for 24 h. After removing the medium, 200. mu.L of samples of different concentrations were added to each well, and 8-10 parallel wells were prepared for each sample. CO at 37 deg.C2Culture boxAfter 20 hours of incubation, 20. mu.L of MTT (detection reagent) (5mg/mL) was added to each well, and after 4 hours of incubation, the precipitate was removed by centrifugation. Then, 150 μ L DMSO (dimethyl sulfoxide) was added to each well, and the cell culture plate was shaken at low speed for 10 min. The absorbance was measured at 490nm with a microplate reader, and finally the cell survival rate (%) was calculated according to the following formula:
cell survival rate (%) ═ B1-B0)*100/B2-B0。
In the formula: b is0Absorbance without cells; b is1Is the absorbance of the added sample; b is2Absorbance without sample.
(2) In vitro construction of intestinal cell model
Caco-2 cells were cultured at 1X 105The density of individual cells/well was seeded in 12-well plates, and the culture medium (Caco-2 cell culture medium, DMEM + 20% FBS as the main component) was changed every other day in the first week, and the culture medium was changed every day in the second week, and after 21 days of culture, an in vitro intestinal cell model was obtained. Removing the Caco-2 cell culture medium, washing twice with selenium-free buffer HBSS (cell culture solution), preheating at 37 ℃ for 10min, removing the HBSS buffer solution, adding samples (selenium-rich active peptide samples of examples 1, 4 and 7) with different concentrations (1mg/mL, 5mg/mL and 10mg/mL), culturing in an incubator for 2 hours, after reaction, washing twice with HBSS buffer solution at 4 ℃ to remove residual extract, adding 500. mu.L of 0.1% (v/v) Triton X-100 cell lysate, repeatedly freezing and thawing to lyse cells, and then performing ultrasonic treatment for 10min to obtain a cell suspension. The total protein mass concentration (g/L) was measured with BCA kit, another portion was removed from the cell suspension, centrifuged at 15000r/min for 10min, and the selenium ion content of the solution and alkaline protease (AKP) activity was determined by atomic absorption spectrophotometer using the AKP activity assay kit. A control group and a sodium selenite group (common selenium supplement products) are arranged in the experimental process, wherein the control group is cells added with culture medium only, and the sodium selenite group is cells added with 0.02mg/mL sodium selenite solution. Meanwhile, the cellular uptake rate was calculated according to the following formula:
the cellular uptake rate (%) ═ C1/C2.
In the formula: c1 is intracellular selenium concentration; c2 is the total cell protein concentration.
As can be seen from the survival rate and selenium uptake data of the small intestinal mucosal cancer cells (Caco-2) in Table 1, the survival rate of the Caco-2 cells treated by the samples of example 1, example 4 and example 7 was above 94%, slightly lower than that of the control group (96.5%) and higher than that of the sodium selenite group, indicating that the samples of the present invention were not toxic to Caco-2. It can also be seen that the uptake rate of selenium by Caco-2 cells was also significantly higher in the samples of examples 1, 4 and 7 than in the sodium selenite group.
TABLE 1 survival of small intestinal mucosal cancer cells (Caco-2) and their uptake of selenium
Experimental example 2 simulated gastrointestinal digestion test
(1) Simulating the gastric digestion stage: simulated Gastric Fluid (SGF) in deionized water was adjusted to pH 2.0, which included 2mg/mL NaCl, 12mmoL/L HCl and 3.2mg/mL pepsin. 5.0mg/mL of the sample (selenium-rich active peptide sample of example 1, example 4, example 7) was mixed with SGF at a mass ratio of 1:1, then adjusted to pH 2.0 and stirred continuously at a constant temperature of 37 ℃ at a rotation speed of 100r/min for 2h to simulate digestion of the stomach, and the supernatant was taken and measured with an atomic absorption spectrophotometer.
(2) Simulating the small intestine digestion stage: preparation of Simulated Intestinal Fluid (SIF): containing salt solution (100mg CaCl)2And 300mg/mL NaCl, pH 7.0), a bile salt solution (375.0mg bile salt dissolved in 7.0mL deionized water, pH 7.0), and an enzyme solution (120.0mg lipase dissolved in 5.0mL deionized water, pH 7.0). After the end of the gastric phase digestion phase, the pH (60.0mL) of the previous solution (the solution mimicking the gastric digestion phase) was raised to 7.0 and the prepared SIF was added to the previous solution to a final concentration of 1.6mg/mL lipase and bile salts. Adjusting pH of the mixture to 7.0, continuously shaking and culturing at 37 deg.C at 100r/min for 2h, collecting, and cold-cooling in ice-water bathHowever, it was then centrifuged at 15000r/min at 4 ℃ for 30min, and the supernatant was taken and measured with an atomic absorption spectrophotometer.
A control group and a sodium selenite group (common selenium supplement products) are arranged in the experimental process, wherein the control group is formed by mixing a sample with deionized water, and the sodium selenite group is formed by mixing a 0.02mg/mL sodium selenite solution with simulated gastric fluid.
Wherein the remaining amount (%) of selenium is 100% of the selenium content of the added digestive juice/the selenium content of the non-added digestive juice.
As can be seen from table 2, no selenium content was detected in the control group during the gastric digestion stage, and the selenium retention of the sodium selenite samples was significantly lower than that of the samples of examples 1, 4 and 7. After gastric digestion, the samples of examples 1, 4 and 7 were also retained higher than the sodium selenite sample during the intestinal digestion phase by performing a second digestion with a combination of the previous gastric juice and simulated intestinal fluid, but the retained amount of selenium was further reduced, probably due to the structural change of the compound caused by trypsin, thereby reducing the binding capacity to selenium. The results show that the selenium-rich active peptide sample has stable structure, is not easily influenced by gastrointestinal digestion, can successfully reach the absorption part of the small intestine and has good tolerance in the stomach and intestine.
TABLE 2 in vitro simulation of selenium retention in the gastric and intestinal stages of digestion
Experimental example 3 animal experiment of digestion and absorption of mice
The 6-week-old clean mice are randomly divided into 3 groups of 12 mice, and the mice are fed with selenium-free feed to establish a low-selenium model, and are fed with drinking water freely and kept at the room temperature of (25 +/-1) ° C. Mice were fasted 6h prior to dosing and had free access to water. Three groups of mice are respectively fed with gastric lavage feed (selenium-rich active peptide samples and sodium selenite in examples 1, 4 and 7) with the selenium content of 18 mug/kg · bw, and 600 mul of blood is taken from tails before and after gastric lavage 5, 10, 20, 30, 40, 60, 80, 100, 120min, and is placed in an EDTA anticoagulant tube, centrifuged for 10min at 3000r/min, and upper plasma is sucked into a centrifuge tube and marked. And (3) detecting the selenium content in the plasma of the mouse by using hydride generation-atomic fluorescence spectrometry (HG-AFS).
As can be seen from table 3, after the selenium-rich active peptide samples of example 1, example 4 and example 7 and the sodium selenite samples were perfused into the gavage mice, the peak values of the blood selenium values in the blood of the mice were all significantly higher than those of the sodium selenite samples, and the peak appearance times of the blood selenium values were all 10 minutes. The reason why the selenium in the selenium-rich active peptide sample is easier to be absorbed and the effect of supplementing selenium is better than that of sodium selenite is probably because the active peptides in the selenium-rich active peptide sample are mainly 6 peptide and 8 peptide compounds and are easy to be absorbed by small intestine and duodenum.
TABLE 3 digestive absorption of selenium after gastric lavage of mice
Group of | Peak Total blood selenium value (mg/L) in mouse blood | Peak time of blood selenium value in mouse blood |
Sodium selenite | 0.81 | 10 |
Example 1 | 1.23 | 10 |
Example 4 | 1.20 | 10 |
Example 7 | 1.99 | 10 |
The embodiments of the present invention have been described in detail, but the present invention is not limited to the described embodiments. It will be apparent to those skilled in the art that various changes, modifications, substitutions and alterations can be made in these embodiments without departing from the principles and spirit of the invention, and the scope of protection is still within the scope of the invention.
Claims (10)
1. A preparation method of active peptide for enhancing selenium absorption is characterized by comprising the following steps:
s1, preparing fish skin into fish paste, adding pepsin for enzymolysis, and collecting supernatant;
s2, adding whey protein powder, cassava starch, carrot powder and selenium-enriched yeast powder into the supernatant obtained in the step S1, and then carrying out anaerobic fermentation;
s3, adding selenoprotein into the fermentation liquor obtained in the step S2, and then carrying out ultrasonic treatment;
s4, uniformly mixing the fish skin mucus and the mulberry leaf juice, standing for a period of time, adding peanut oil and algal polysaccharide, and then homogenizing and stirring;
s5, adding the solution obtained in the step S4 into the fermentation liquid obtained in the step S3, vacuumizing, performing high static pressure treatment, and finally reducing the pressure to obtain the selenium absorption enhancing active peptide.
2. The method of claim 1, wherein the fish skin and the fish skin mucus are from snakeheads.
3. The method of claim 1, wherein in step S2, whey protein powder, tapioca starch and carrot powder are added to the supernatant, and after heating to 30 ℃, selenium-rich yeast powder is added, and finally the temperature is raised to 37 ℃ for anaerobic fermentation.
4. The method of claim 3, wherein in step S2, the whey protein powder is added in an amount of 0.5-1.5%, the tapioca starch is added in an amount of 2.5-2.8%, the carrot powder is added in an amount of 0.3-0.5%, and the selenium-enriched yeast powder is added in an amount of 0.2-0.3% by mass of the supernatant.
5. The method of claim 1, wherein in step S4, the volume ratio of the fish skin mucus to mulberry leaf juice is 1: 1.
6. The method of claim 1, wherein the high static pressure treatment is 300-350MPa for 10 minutes in step S5.
7. The selenium absorption-enhanced active peptide prepared by the preparation method of any one of claims 1 to 6.
8. Use of the selenium absorption-enhancing active peptide of claim 7 for the preparation of selenium-enriched health food.
9. A preparation method of a selenium-enriched emulsion beverage for enhancing selenium absorption is characterized in that 1.8-2 wt% of whey protein, (0.002-0.003) wt% of lactoferrin, (0.1-0.15) wt% of edible fungus superfine powder, (1.3-2.0) wt% of maltodextrin, (1.3-2.0) wt% of perilla extract and (1.3-2.0) wt% of glucose are added into the selenium absorption enhancing active peptide of claim 7, and the selenium absorption enhancing active peptide is obtained by stirring, uniformly mixing and then sterilizing at high temperature.
10. A preparation method of selenium-rich health powder for enhancing selenium absorption is characterized in that the selenium-absorption enhancing active peptide of claim 7 is dried into powder, then added with (5-6) wt% whey protein powder, (0.6-1.2) wt% walnut powder, (0.001-0.0015) wt% lactoferrin, (0.8-1.0) wt% edible fungus superfine powder, (8-10) wt% maltodextrin and (0.005-0.01) wt% solid DHA powder, and the selenium-rich health powder is obtained after uniform mixing and packaging.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011414163.6A CN112481341B (en) | 2020-12-07 | 2020-12-07 | Preparation method and application of selenium absorption enhancing active peptide |
AU2020104369A AU2020104369A4 (en) | 2020-12-07 | 2020-12-29 | Preparation Method of Active Peptide for Enhancing Selenium Absorption and Application Thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011414163.6A CN112481341B (en) | 2020-12-07 | 2020-12-07 | Preparation method and application of selenium absorption enhancing active peptide |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112481341A true CN112481341A (en) | 2021-03-12 |
CN112481341B CN112481341B (en) | 2022-09-23 |
Family
ID=74940272
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011414163.6A Active CN112481341B (en) | 2020-12-07 | 2020-12-07 | Preparation method and application of selenium absorption enhancing active peptide |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN112481341B (en) |
AU (1) | AU2020104369A4 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112970997A (en) * | 2021-04-02 | 2021-06-18 | 汕尾市五丰海洋生物科技有限公司 | Preparation method of selenoprotein powder and selenoprotein tablet |
CN114752642A (en) * | 2022-03-24 | 2022-07-15 | 华南农业大学 | Selenium-rich walnut antihypertensive peptide, and preparation method and application thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017026173A1 (en) * | 2015-08-07 | 2017-02-16 | キッコーマン株式会社 | Method for producing selenoneine |
CN108893514A (en) * | 2018-07-20 | 2018-11-27 | 广州医科大学 | A kind of whey protein peptide with antioxidant activity-selenium chelate and its preparation method and application |
CN109430526A (en) * | 2018-12-27 | 2019-03-08 | 广西壮佳霖农业投资有限公司 | A kind of lactalbumin Se-enriched bio feed and its application |
US20200077682A1 (en) * | 2015-01-16 | 2020-03-12 | Welldrinks Ltd | Beverage with collagen and additional additives |
-
2020
- 2020-12-07 CN CN202011414163.6A patent/CN112481341B/en active Active
- 2020-12-29 AU AU2020104369A patent/AU2020104369A4/en not_active Ceased
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20200077682A1 (en) * | 2015-01-16 | 2020-03-12 | Welldrinks Ltd | Beverage with collagen and additional additives |
WO2017026173A1 (en) * | 2015-08-07 | 2017-02-16 | キッコーマン株式会社 | Method for producing selenoneine |
CN108893514A (en) * | 2018-07-20 | 2018-11-27 | 广州医科大学 | A kind of whey protein peptide with antioxidant activity-selenium chelate and its preparation method and application |
CN109430526A (en) * | 2018-12-27 | 2019-03-08 | 广西壮佳霖农业投资有限公司 | A kind of lactalbumin Se-enriched bio feed and its application |
Non-Patent Citations (1)
Title |
---|
林栋等: "核桃多肽-硒螯合物制备工艺优化及其抗氧化活性研究", 《食品科技》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112970997A (en) * | 2021-04-02 | 2021-06-18 | 汕尾市五丰海洋生物科技有限公司 | Preparation method of selenoprotein powder and selenoprotein tablet |
CN114752642A (en) * | 2022-03-24 | 2022-07-15 | 华南农业大学 | Selenium-rich walnut antihypertensive peptide, and preparation method and application thereof |
Also Published As
Publication number | Publication date |
---|---|
CN112481341B (en) | 2022-09-23 |
AU2020104369A4 (en) | 2021-03-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101228951B (en) | Preparing method of biologic compound amylose nutrient fluid | |
CN112481341B (en) | Preparation method and application of selenium absorption enhancing active peptide | |
CN104663246B (en) | The production method of selenium-enriched high-calcium edible fungus cluster | |
CN107625125A (en) | A kind of Tiny ecosystem eats ferment and preparation method thereof | |
CN106754142A (en) | A kind of deer-blood wine and preparation method thereof | |
CN107549817B (en) | Moringa oleifera natural organic calcium and preparation method thereof | |
CN101875958B (en) | Method for improving glutathione content in selenium-enriched Candida utilis | |
CN104642142A (en) | Mutation breeding method of lucid ganoderma strains | |
CN104450826A (en) | Coriolus versicolor polysaccharide extracts and preparation method and application thereof | |
CN102492759A (en) | Method for preparing soluble corn peptide from Aspergillus niger fermented maize yellow powder | |
CN116925938B (en) | Yeast protein powder and preparation method thereof | |
CN105876764A (en) | Preparation technology of fermented mushroom sauce | |
CN103922819B (en) | Meat lucid ganoderma nutrient solution preparation method and rapid meat lucid ganoderma culture method | |
CN109259223B (en) | Method for processing Yunnan ginseng enzyme | |
CN107027516A (en) | A kind of selenium-rich Periostracum cicadae, its cultural method and application | |
CN104621429B (en) | A kind of selenium-rich organic appetite-stimulating indigestion-relieving jam | |
CN110592161A (en) | Preparation method of polysaccharide, health-care oral liquid and preparation method | |
CN107896921B (en) | Tremella biotransformation composition of maca and dioscorea opposita and preparation method thereof | |
CN105535035A (en) | Inonotus obliquus fermentation culture composition and preparation method thereof | |
CN106635834B (en) | The Thelephora ganbajun mycelium zinc polysaccharide and application that one plant of wizened bacteria strain and its fermentation obtain | |
CN105661247A (en) | Grape composite powder and preparation method thereof | |
CN109771452A (en) | Application of the Pleurotus tuber-regium extract in preparation tumor | |
CN112616991A (en) | Method for extracting protein in chlorella and application of protein in sweet potato chlorella meal replacement powder | |
CN111139277A (en) | Crude polysaccharide and preparation process thereof, health-care oral liquid and preparation method thereof | |
CN1632128A (en) | Organic selenium from aspergillus oryzae and method for preparing same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: 510610 Guangdong, Guangzhou, Tianhe District province Dongguan Zhuang Road, No. 133 Applicant after: SERICULTURE & AGRI FOOD Research Institute GAAS Address before: 510275 No. 135 West Xingang Road, Guangzhou, Guangdong, Haizhuqu District Applicant before: SERICULTURE & AGRI FOOD Research Institute GAAS |
|
GR01 | Patent grant | ||
GR01 | Patent grant |